CN112515070A - 一种含虾青素、牛磺酸、烟酰胺单核苷酸及电解质的运动饮料及制作方法 - Google Patents
一种含虾青素、牛磺酸、烟酰胺单核苷酸及电解质的运动饮料及制作方法 Download PDFInfo
- Publication number
- CN112515070A CN112515070A CN202011254045.3A CN202011254045A CN112515070A CN 112515070 A CN112515070 A CN 112515070A CN 202011254045 A CN202011254045 A CN 202011254045A CN 112515070 A CN112515070 A CN 112515070A
- Authority
- CN
- China
- Prior art keywords
- vitamin
- sports
- taurine
- astaxanthin
- proper amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 title claims abstract description 70
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 title claims abstract description 46
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 title claims abstract description 46
- 229940022405 astaxanthin Drugs 0.000 title claims abstract description 46
- 235000013793 astaxanthin Nutrition 0.000 title claims abstract description 46
- 239000001168 astaxanthin Substances 0.000 title claims abstract description 46
- DAYLJWODMCOQEW-TURQNECASA-O NMN(+) Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(O)=O)O2)O)=C1 DAYLJWODMCOQEW-TURQNECASA-O 0.000 title claims abstract description 42
- 229960003080 taurine Drugs 0.000 title claims abstract description 35
- 235000013361 beverage Nutrition 0.000 title claims abstract description 32
- 239000003792 electrolyte Substances 0.000 title claims abstract description 28
- 238000002360 preparation method Methods 0.000 title abstract description 8
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 26
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims abstract description 24
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract description 24
- 229930003270 Vitamin B Natural products 0.000 claims abstract description 22
- 235000019156 vitamin B Nutrition 0.000 claims abstract description 22
- 239000011720 vitamin B Substances 0.000 claims abstract description 22
- 239000000375 suspending agent Substances 0.000 claims abstract description 14
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 13
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 13
- 235000011496 sports drink Nutrition 0.000 claims abstract description 13
- 239000011718 vitamin C Substances 0.000 claims abstract description 13
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 13
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 12
- 239000008103 glucose Substances 0.000 claims abstract description 12
- 239000001103 potassium chloride Substances 0.000 claims abstract description 12
- 235000011164 potassium chloride Nutrition 0.000 claims abstract description 12
- 239000011780 sodium chloride Substances 0.000 claims abstract description 12
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims abstract description 11
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 claims abstract description 11
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims abstract description 11
- 235000019796 monopotassium phosphate Nutrition 0.000 claims abstract description 11
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000002904 solvent Substances 0.000 claims description 18
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 14
- 230000001954 sterilising effect Effects 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 10
- 239000008367 deionised water Substances 0.000 claims description 10
- 229910021641 deionized water Inorganic materials 0.000 claims description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 9
- 238000011049 filling Methods 0.000 claims description 9
- 238000004659 sterilization and disinfection Methods 0.000 claims description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 6
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 claims description 6
- 235000019441 ethanol Nutrition 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 claims description 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 5
- 239000003960 organic solvent Substances 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 claims description 4
- RGSFGYAAUTVSQA-UHFFFAOYSA-N Cyclopentane Chemical compound C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 claims description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 4
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 claims description 4
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 claims description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 4
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 claims description 4
- YRKCREAYFQTBPV-UHFFFAOYSA-N acetylacetone Chemical compound CC(=O)CC(C)=O YRKCREAYFQTBPV-UHFFFAOYSA-N 0.000 claims description 4
- 150000001335 aliphatic alkanes Chemical class 0.000 claims description 4
- 150000001413 amino acids Chemical class 0.000 claims description 4
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 claims description 4
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 claims description 4
- 150000002430 hydrocarbons Chemical group 0.000 claims description 4
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 claims description 4
- 150000002576 ketones Chemical class 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- 229910052757 nitrogen Inorganic materials 0.000 claims description 4
- 229960004063 propylene glycol Drugs 0.000 claims description 4
- 235000013772 propylene glycol Nutrition 0.000 claims description 4
- 238000007789 sealing Methods 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- 150000003457 sulfones Chemical group 0.000 claims description 4
- 229920000858 Cyclodextrin Polymers 0.000 claims description 3
- 238000009924 canning Methods 0.000 claims description 3
- 150000001875 compounds Chemical class 0.000 claims description 3
- 150000002148 esters Chemical class 0.000 claims description 3
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims description 3
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 claims description 2
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 claims description 2
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 claims description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 2
- 239000004215 Carbon black (E152) Substances 0.000 claims description 2
- 229920001661 Chitosan Polymers 0.000 claims description 2
- 239000004375 Dextrin Substances 0.000 claims description 2
- 229920001353 Dextrin Polymers 0.000 claims description 2
- KMTRUDSVKNLOMY-UHFFFAOYSA-N Ethylene carbonate Chemical compound O=C1OCCO1 KMTRUDSVKNLOMY-UHFFFAOYSA-N 0.000 claims description 2
- 229920000881 Modified starch Polymers 0.000 claims description 2
- 239000004368 Modified starch Substances 0.000 claims description 2
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 2
- 229920001219 Polysorbate 40 Polymers 0.000 claims description 2
- 229920001214 Polysorbate 60 Polymers 0.000 claims description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 claims description 2
- 150000001298 alcohols Chemical class 0.000 claims description 2
- 239000000783 alginic acid Substances 0.000 claims description 2
- 235000010443 alginic acid Nutrition 0.000 claims description 2
- 229920000615 alginic acid Polymers 0.000 claims description 2
- 229960001126 alginic acid Drugs 0.000 claims description 2
- 150000004781 alginic acids Chemical class 0.000 claims description 2
- 239000001273 butane Substances 0.000 claims description 2
- 229910052799 carbon Chemical group 0.000 claims description 2
- 239000001913 cellulose Substances 0.000 claims description 2
- 229920002678 cellulose Polymers 0.000 claims description 2
- 235000019425 dextrin Nutrition 0.000 claims description 2
- CCAFPWNGIUBUSD-UHFFFAOYSA-N diethyl sulfoxide Chemical compound CCS(=O)CC CCAFPWNGIUBUSD-UHFFFAOYSA-N 0.000 claims description 2
- CZZYITDELCSZES-UHFFFAOYSA-N diphenylmethane Chemical compound C=1C=CC=CC=1CC1=CC=CC=C1 CZZYITDELCSZES-UHFFFAOYSA-N 0.000 claims description 2
- 230000032050 esterification Effects 0.000 claims description 2
- 238000005886 esterification reaction Methods 0.000 claims description 2
- 150000002170 ethers Chemical class 0.000 claims description 2
- JBTWLSYIZRCDFO-UHFFFAOYSA-N ethyl methyl carbonate Chemical compound CCOC(=O)OC JBTWLSYIZRCDFO-UHFFFAOYSA-N 0.000 claims description 2
- WBJINCZRORDGAQ-UHFFFAOYSA-N formic acid ethyl ester Natural products CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 claims description 2
- 125000000524 functional group Chemical group 0.000 claims description 2
- 239000003502 gasoline Substances 0.000 claims description 2
- 235000011187 glycerol Nutrition 0.000 claims description 2
- DMEGYFMYUHOHGS-UHFFFAOYSA-N heptamethylene Natural products C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 claims description 2
- 229930195733 hydrocarbon Natural products 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- 235000019426 modified starch Nutrition 0.000 claims description 2
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 claims description 2
- 231100000252 nontoxic Toxicity 0.000 claims description 2
- 230000003000 nontoxic effect Effects 0.000 claims description 2
- 150000002894 organic compounds Chemical class 0.000 claims description 2
- 239000003208 petroleum Substances 0.000 claims description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 2
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 claims description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 2
- 229920001282 polysaccharide Polymers 0.000 claims description 2
- 239000005017 polysaccharide Substances 0.000 claims description 2
- 150000004804 polysaccharides Chemical class 0.000 claims description 2
- 229920000053 polysorbate 80 Polymers 0.000 claims description 2
- 239000001294 propane Substances 0.000 claims description 2
- 108090000623 proteins and genes Proteins 0.000 claims description 2
- 102000004169 proteins and genes Human genes 0.000 claims description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims 3
- 208000029549 Muscle injury Diseases 0.000 abstract description 4
- 239000013589 supplement Substances 0.000 abstract description 4
- 230000003647 oxidation Effects 0.000 abstract description 3
- 238000007254 oxidation reaction Methods 0.000 abstract description 3
- 230000008439 repair process Effects 0.000 abstract description 2
- 208000000112 Myalgia Diseases 0.000 abstract 1
- 208000015001 muscle soreness Diseases 0.000 abstract 1
- 206010016256 fatigue Diseases 0.000 description 11
- BAWFJGJZGIEFAR-NNYOXOHSSA-O NAD(+) Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-O 0.000 description 9
- 229950006238 nadide Drugs 0.000 description 8
- 150000003254 radicals Chemical class 0.000 description 8
- 230000006378 damage Effects 0.000 description 6
- 230000001105 regulatory effect Effects 0.000 description 6
- 208000027418 Wounds and injury Diseases 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 208000014674 injury Diseases 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- -1 3 ' -dihydroxy-4 Chemical compound 0.000 description 3
- 238000012371 Aseptic Filling Methods 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 241000168517 Haematococcus lacustris Species 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000000887 hydrating effect Effects 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000003859 lipid peroxidation Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 2
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000035806 respiratory chain Effects 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 description 1
- 206010001497 Agitation Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000025978 Athletic injury Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 239000004380 Cholic acid Substances 0.000 description 1
- XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 1
- 108020005199 Dehydrogenases Proteins 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 206010062767 Hypophysitis Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010041738 Sports injury Diseases 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 230000009102 absorption Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000008499 blood brain barrier function Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001218 blood-brain barrier Anatomy 0.000 description 1
- 210000002937 blood-testis barrier Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 210000004413 cardiac myocyte Anatomy 0.000 description 1
- 210000002390 cell membrane structure Anatomy 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000019416 cholic acid Nutrition 0.000 description 1
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 1
- 229960002471 cholic acid Drugs 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000009982 effect on human Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 230000004110 gluconeogenesis Effects 0.000 description 1
- 230000034659 glycolysis Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000002064 heart cell Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 125000000468 ketone group Chemical group 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 230000020958 lipid digestion Effects 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 239000012263 liquid product Substances 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000006241 metabolic reaction Methods 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 239000004530 micro-emulsion Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 210000001700 mitochondrial membrane Anatomy 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 230000007830 nerve conduction Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 230000037081 physical activity Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 210000004560 pineal gland Anatomy 0.000 description 1
- 210000003635 pituitary gland Anatomy 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229940034208 thyroxine Drugs 0.000 description 1
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- ODLHGICHYURWBS-LKONHMLTSA-N trappsol cyclo Chemical compound CC(O)COC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)COCC(O)C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1COCC(C)O ODLHGICHYURWBS-LKONHMLTSA-N 0.000 description 1
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 1
- 230000004382 visual function Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/60—Sweeteners
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Non-Alcoholic Beverages (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
本发明公开了一种含虾青素、牛磺酸、烟酰胺单核苷酸及电解质的运动饮料及制作方法，所述运动饮料每250mL包括虾青素8‑12mg、烟酰胺单核苷酸8‑10mg、牛磺酸50‑125mg、维生素C25‑75mg、维生素B6 0.1‑0.3mg、维生素B12 0.1‑0.45mg、葡萄糖5‑10g、香精适量、悬浮剂适量、氯化钠2.0g、氯化钾0.1g、碳酸氢钠0.09g、磷酸二氢钾0.02g、磷酸氢二钠0.04g。本发明的含虾青素、牛磺酸、烟酰胺单核苷酸及电解质的运动饮料既能清除运动产生的自由基，缓解运动疲劳和肌肉酸痛，修复肌肉损伤，又能提供能量，补充电解质，增加机体耐力，是一款抗氧化、缓解体力疲劳的饮料。
Description
技术领域
本发明涉及食品加工技术领域，具体来说，涉及一种含虾青素、牛磺酸、烟酰胺单核苷酸及电解质的运动饮料及制作方法。
背景技术
虾青素(astaxanthin)即3,3′-二羟基-4,4′-二酮基-β,β′-胡萝卜素，不溶于水,易溶于有机溶剂。天然虾青素为目前发现最强的天然抗氧化剂之一，其不饱和酮基和羟基具有比较活泼的电子效应，能吸引自由基未配对电子或向自由基提供电子，有效清除细胞内的氧自由基，虾青素还能增强免疫、抗炎、改善视力、抗高血压、预防心血管疾病、抗癌、抗衰老、预防神经退行性病变等多种生理功能。虾青素还具有穿透体内多种屏障(如血脑屏障、血眼屏障、血睾屏障)的能力。雨生红球藻为目前自然界中发现的天然虾青素含量最高生物，含量1～5％，所含的天然虾青素几乎全为左旋形式，活性最佳。继美国和欧盟以后，雨生红球藻于2010年11月被我国卫生部批准为新资源食品，食用安全可靠。
虾青素可以改善运动疲劳损伤及引起的炎症反应。虾青素抗氧化作用能抵抗自由基氧化损伤所致的关节疼痛和关节炎。运动性损伤后产生的大量炎性因子会导致病情加重，虾青素具有抗炎症作用，能够抵抗炎性因子产生的炎症作用，改善运动损伤的程度及防止诱发其他症状，并促进运动损伤的恢复。虾青素增强肌肉细胞代谢能力增强肌肉耐力。虾青素的强抗氧化性可以降低脂质过氧化水平来改善脂质代谢，保证细胞内平衡及线粒体正常供能，降低血乳酸堆积，增进肌肉耐受力，提高运动过程中耐力水平，减少肌肉质量的降低，防止运动性疲劳的产生，对运动性肌肉损伤具有治疗作用，同时增强了运动能力（苏铁柱.虾青素的生理功能及其在运动中的应用.商洛学院学报,2014,28(02):87-91.）。
牛磺酸（Taurine）即2-氨基乙磺酸，含硫氨基酸，在人和动物胆汁中与胆酸以结合形式存在；而在脑、松果体、垂体、视网膜、等组织中，以游离形式大量存在，不参与蛋白质的合成。牛磺酸是人体的条件必需氨基酸，对胎儿、婴儿神经系统的发育有重要作用。牛磺酸也是调节机体正常生理活动的活性物质，具有消炎、镇痛、维持机体渗透压平衡、维持正常视觉功能、调节细胞钙平衡、降血糖、调节神经传导、参与内分泌活动、调节脂类消化与吸收、增加心脏收缩能力、提高机体免疫能力、增强细胞膜抗氧化能力、保护心肌细胞等广泛的生物学功能。我国于1990年开始允许牛磺酸作为营养食品添加剂加入乳制品、饮料和复合调味品中，允许加入量为30～40mg/kg。
牛磺酸可以减少运动损伤，延缓疲劳。通过抑制脂质过氧化、抑制运动过程中所产生的自由基以及对心肌细胞Ca2+的调节,从而对心肌细胞膜以及线粒体膜或脑细胞膜均有保护作用,促进细胞膜结构和功能的恢复延缓疲劳的出现。通过调节神经递质而使中枢神经系统保持良好的应激状态。牛磺酸还可以影响甲状腺素的分泌，从而使心肌免受运动应激性损伤。通过调节人体内支链氨基酸浓度来保持中枢兴奋状态, 延迟运动性疲劳的出现或减轻疲劳程度（柯杰兵.牛磺酸代谢及其抗疲劳机理.解放军体育学院学报,1999(03):3-5.）。
烟酰胺单核苷酸（NMN）是人体内固有的物质，也富含在一些水果和蔬菜中。NMN在人体细胞能量生成中扮演重要角色，在人体中NMN是烟酰胺腺嘌呤二核苷酸（NAD+）最直接的前体，参与细胞内NAD+的合成，其功能是多是通过NAD+体现的。在多种细胞代谢反应中，NAD+都扮演着重要角色，是细胞保持活力的重要支撑。
NAD+是脱氢酶的辅酶，它在糖酵解，糖异生，三羧酸循环和呼吸链中发挥着不可替代的作用。中间产物会将脱下的氢递给NAD+，使之成为NADH。而NADH则会作为氢的载体，在呼吸链中通过化学渗透偶联的方式，合成ATP。NAD+分子比较大，是NMN的两倍。口服的NAD+会被分解掉，而注射虽然可以进入血液循环，无法直接穿过细胞膜的，无法进入细胞内部，也就不能对人体产生效果。因此NMN还是最好的NAD+补充剂。
运动过程中往往容易产生大量损伤机体的自由基及代谢产物，出现运动性疲劳甚至运动性损伤等，影响正常运动或降低运动能力。中国饮料协会对运动饮料定义为“营养成分及其含量能适应运动或体力活动人群的生理特点，能为机体补充水分、电解质、能量和(或)有助于运动后机体恢复，可被迅速吸收的预包装液体制品”，目前市面上的商品其通常含有碳水化合物、矿物质、电解质、维生素和其他类营养物质，多为营养补充剂，少有机体修复剂。
发明内容
针对相关技术中的上述技术问题，本发明提出一种含虾青素、牛磺酸、烟酰胺单核苷酸及电解质的运动饮料及制作方法，能够克服现有技术的上述不足。
为实现上述技术目的，本发明的技术方案是这样实现的：
一种含虾青素、牛磺酸、烟酰胺单核苷酸及电解质的运动饮料，按每250mL含量计，包括虾青素8-12mg、烟酰胺单核苷酸8-10mg、牛磺酸50-125mg、维生素C 25-75mg、维生素B60.1-0.3mg、维生素B12 0.1-0.45mg、葡萄糖5-10g、香精适量、悬浮剂适量、氯化钠2.0g、氯化钾0.1g、碳酸氢钠0.09g、磷酸二氢钾0.02g、磷酸氢二钠0.04g。
根据本发明的另一方面，提供了所述运动饮料的制作方法，包括以下步骤：
S1取12mg虾青素，采用100mg包合性壁材进行包埋得到混合物，或者溶于适量有机溶剂中，无氧罐装至饮料瓶内的贮存室，充氮、密封，备用；
S2取去离子水200 mL，依次加入烟酰胺单核苷酸8-10mg、牛磺酸50-125mg、维生素C 25-75mg、维生素B6 0.1-0.3mg、维生素B12 0.1-0.45mg、葡萄糖5-10g、香精适量、悬浮剂适量、氯化钠2.0g、氯化钾0.1g、碳酸氢钠0.09g、磷酸二氢钾0.02g、磷酸氢二钠0.04g，香精适量，悬浮剂适量，充分搅拌至完全溶解水化，用去离子水定容至250mL；
S3杀菌、灌装：将步骤S2处理后得到的料液，经温度125℃、时间5秒高温瞬时灭菌，然后进行无菌灌装至所述饮料瓶内，得到产品。
优选地，所述贮存室位于所述饮料瓶的瓶盖中。
优选地，步骤S3高温瞬时灭菌的温度为125℃。
优选地，步骤S3高温瞬时灭菌的时间为5秒。
优选地，包合性壁材选自以下一种或多种：环糊精及各类衍生物、改性淀粉衍生物、改性纤维素衍生物、壳聚糖酯化及其衍生物、酯化蛋白、酯化氨基酸、酯化多糖、酯化胶类物质、酯化海藻酸、酯化糊精。
优选地，所述有机溶剂选自砜类、醇类、酯类、酮类、醚类、烷类无毒或低毒溶剂，6号轻汽油、四氢呋喃、三氟代乙酸可混溶于前述溶剂的溶剂或助剂；其中砜类溶剂包括二甲基亚砜、二乙基亚砜、苄苯亚砜；醇类溶剂包括分子中含有跟烃基或苯环侧链上的碳结合的羟基的化合物，或烃分子中一个或几个氢被羟基取代而生成的一类有机化合物，其官能团为-OH，包括但不限于乙醇、苯甲醇、丙二醇、丙三醇、乙二醇、戊醇、己醇、正己醇、正丁醇、异丙醇、异丁醇、1-丁醇、1，2-丙二醇、二甘醇；酯类溶剂包括甲酸乙酯、乙酸乙酯等（甲～癸）酸（甲～癸）酯及其衍生物、乙二醇碳酸酯聚、氧乙烯 (20)山梨醇酐单月桂酸酯,聚氧乙烯(20)山梨醇酐单棕榈酸酯,聚氧乙烯(20)山梨醇酐单硬脂酸酯,聚氧乙烯(20)山梨醇酐单油酸酯；烷类溶剂包括丙烷、1,2-二氯乙烷、丁烷、戊烷、环戊烷；酮类溶剂包括丙酮、乙酰丙酮、丁酮、环己酮；醚类溶剂包括乙醚、石油醚、乙二醇一甲醚。
本发明的有益效果：本发明的含虾青素、牛磺酸、烟酰胺单核苷酸及电解质的运动饮料通过添加虾青素、牛磺酸、烟酰胺单核苷酸（NMN）及电解质，从而既能清除运动产生的自由基，缓解运动疲劳和酸痛，修复肌肉损伤，又能提供能量，补充电解质，增加机体耐力，是一款新颖的抗氧化、缓解体力疲劳的运动饮料。
具体实施方式
下面将对本发明实施例中的技术方案进行清楚、完整地描述，显然，所描述的实施例仅仅是本发明一部分实施例，而不是全部的实施例。基于本发明中的实施例，本领域普通技术人员所获得的所有其他实施例，都属于本发明保护的范围。
实施例1
一种含虾青素、牛磺酸、烟酰胺单核苷酸及电解质的运动饮料，所含成分（250mL运动饮料）为：虾青素12mg，烟酰胺单核苷酸（NMN）10mg，牛磺酸125mg，维生素C 75mg，维生素B6 0.3mg，维生素B12 0.45mg，葡萄糖5g，香精适量，悬浮剂适量及电解质；电解质为：氯化钠2.0g，氯化钾 0.1g，碳酸氢钠0.09g，磷酸二氢钾0.02g，磷酸氢二钠0.04g。
所述运动饮料的制备方法为：
S1取虾青素12mg，采用羟丙基-β-环糊精100mg进行包埋得到混合物，无氧罐装至贮存室（如瓶盖中），充氮、密封，备用；
S2取去离子水200mL，依次加入烟酰胺单核苷酸（NMN）10mg，牛磺酸125mg，维生素C75mg，维生素B6 0.3mg，维生素B12 0.45mg，葡萄糖5g，氯化钠2.0g，氯化钾 0.1g，碳酸氢钠0.09g，磷酸二氢钾 0.02g，磷酸氢二钠 0.04g，香精0.6g，悬浮剂0.5g，充分搅拌至完全溶解水化，用去离子水定容至250mL；
S3杀菌、灌装：处理后的料液，经温度125℃、时间5秒高温瞬时灭菌，然后进行无菌灌装，得到产品。
实施例2
一种含虾青素、牛磺酸、烟酰胺单核苷酸及电解质的运动饮料，所含成分（250mL运动饮料）为：虾青素12mg，烟酰胺单核苷酸（NMN）10mg，牛磺酸125mg，维生素C 75mg，维生素B6 0.3mg，维生素B12 0.45mg，葡萄糖10g， 香精适量，悬浮剂适量及电解质；电解质为：氯化钠2.0g，氯化钾 0.1g，碳酸氢钠0.09g，磷酸二氢钾0.02g，磷酸氢二钠0.04g。
所述运动饮料的制备方法为：
S1 虾青素（净含12mg）微乳剂，溶于溶剂中，无氧罐装至贮存室（如瓶盖中），充氮、密封，备用；
S2 去离子水200mL，依次加入烟酰胺单核苷酸（NMN）10mg，牛磺酸125mg，维生素C75mg，维生素B6 0.3mg，维生素B12 0.45mg，葡萄糖10g，电解质（如下）：氯化钠2.0g，氯化钾0.1g，碳酸氢钠0.09g，磷酸二氢钾 0.02g，磷酸氢二钠 0.04g，香精0.8g，悬浮剂1.2g，充分搅拌至完全溶解水化，用去离子水定容至250mL；
S3 杀菌、灌装：处理后的料液，经温度125℃、时间5秒高温瞬时灭菌，然后进行无菌灌装，得到产品。
由于虾青素的不稳定性，且因为电解质的缘故，必须将虾青素和其他溶液分开。具体操作为，将虾青素采用环糊精进行包被后溶于相关溶剂后，贮存在饮料瓶内特殊贮存室中（如盖子），使用时通过旋动盖子，压破贮存室，虾青素流入饮料中，混匀即可饮用。
实施例3
一种含虾青素、牛磺酸、烟酰胺单核苷酸及电解质的运动饮料，所含成分（250mL运动饮料）为：虾青素12mg，烟酰胺单核苷酸（NMN）10mg，牛磺酸125mg，维生素C 75mg，维生素B6 0.3mg，维生素B12 0.45mg，葡萄糖5g，香精适量，悬浮剂适量及电解质；电解质为：氯化钠2.0g，氯化钾 0.1g，碳酸氢钠0.09g，磷酸二氢钾0.02g，磷酸氢二钠0.04g。
所述运动饮料的制备方法为：
S1取虾青素12mg，采用适量乙酸乙酯溶解，罐装至贮存室（如瓶盖中），隔氧、避光密封，备用；
S2取去离子水200mL，依次加入烟酰胺单核苷酸（NMN）10mg，牛磺酸125mg，维生素C75mg，维生素B6 0.3mg，维生素B12 0.45mg，葡萄糖5g，氯化钠2.0g，氯化钾 0.1g，碳酸氢钠0.09g，磷酸二氢钾 0.02g，磷酸氢二钠 0.04g，香精0.6g，悬浮剂0.5g，充分搅拌至完全溶解水化，用去离子水定容至250mL；
S3杀菌、灌装：处理后的料液，经温度125℃、时间5秒高温瞬时灭菌，然后进行无菌灌装，得到产品。
使用时，储存室打开，将虾青素液倒入下层饮料，混合使用即可。
综上所述，借助于本发明的上述技术方案，通过添加虾青素、牛磺酸、烟酰胺单核苷酸（NMN）及电解质，从而既能清除运动产生的自由基，缓解运动疲劳和酸痛，修复肌肉损伤，又能提供能量，补充电解质，增加机体耐力，是一款新颖的抗氧化、缓解体力疲劳的运动饮料。
以上所述仅为本发明的较佳实施例而已，并不用以限制本发明，凡在本发明的精神和原则之内，所作的任何修改、等同替换、改进等，均应包含在本发明的保护范围之内。
Claims (7)
1. 一种含虾青素、牛磺酸、烟酰胺单核苷酸及电解质的运动饮料，其特征在于，按每250mL含量计，包括虾青素8-12mg、烟酰胺单核苷酸8-10mg、牛磺酸50-125mg、维生素C 25-75mg、维生素B6 0.1-0.3mg、维生素B12 0.1-0.45mg、葡萄糖5-10g、香精适量、悬浮剂适量、氯化钠2.0g、氯化钾0.1g、碳酸氢钠0.09g、磷酸二氢钾0.02g、磷酸氢二钠0.04g。
2.一种如权利要求1所述的运动饮料的制作方法，其特征在于，包括以下步骤：
S1取12mg虾青素，采用100mg包合性壁材进行包埋得到混合物，或者溶于适量有机溶剂中，无氧罐装至饮料瓶内的贮存室，充氮、密封，备用；
S2取去离子水200 mL，依次加入烟酰胺单核苷酸8-10mg、牛磺酸50-125mg、维生素C25-75mg、维生素B6 0.1-0.3mg、维生素B12 0.1-0.45mg、葡萄糖5-10g、香精适量、悬浮剂适量、氯化钠2.0g、氯化钾0.1g、碳酸氢钠0.09g、磷酸二氢钾0.02g、磷酸氢二钠0.04g，香精适量，悬浮剂适量，充分搅拌至完全溶解水化，用去离子水定容至250mL；
S3杀菌、灌装：将步骤S2处理后得到的料液，经温度125℃、时间5秒高温瞬时灭菌，然后进行无菌灌装至所述饮料瓶内，得到产品。
3.根据权利要求2所述的运动饮料的制作方法，其特征在于，所述贮存室位于所述饮料瓶的瓶盖中。
4.根据权利要求2所述的运动饮料的制作方法，其特征在于，步骤S3高温瞬时灭菌的温度为125℃。
5.根据权利要求2所述的运动饮料的制作方法，其特征在于，步骤S3高温瞬时灭菌的时间为5秒。
6.根据权利要求2所述的运动饮料的制作方法，其特征在于，所述包合性壁材选自以下一种或多种：环糊精及其各类衍生物、改性淀粉衍生物、改性纤维素衍生物、壳聚糖酯化及其衍生物、酯化蛋白、酯化氨基酸、酯化多糖、酯化胶类物质、酯化海藻酸、酯化糊精。
7.根据权利要求2所述的运动饮料的制作方法，其特征在于，所述有机溶剂选自砜类、醇类、酯类、酮类、醚类、烷类无毒或低毒溶剂，6号轻汽油、四氢呋喃、三氟代乙酸可混溶于前述溶剂的溶剂或助剂；其中，砜类溶剂包括二甲基亚砜、二乙基亚砜、苄苯亚砜；醇类溶剂包括分子中含有跟烃基或苯环侧链上的碳结合的羟基的化合物，或烃分子中一个或几个氢被羟基取代而生成的一类有机化合物，其官能团为-OH，包括但不限于乙醇、苯甲醇、丙二醇、丙三醇、乙二醇、戊醇、己醇、正己醇、正丁醇、异丙醇、异丁醇、1-丁醇、1，2-丙二醇、二甘醇；酯类溶剂包括甲酸乙酯、乙酸乙酯及其衍生物、乙二醇碳酸酯聚、氧乙烯(20)山梨醇酐单月桂酸酯、聚氧乙烯(20)山梨醇酐单棕榈酸酯、聚氧乙烯(20)山梨醇酐单硬脂酸酯、聚氧乙烯(20)山梨醇酐单油酸酯；烷类溶剂包括丙烷、1,2-二氯乙烷、丁烷、戊烷、环戊烷；酮类溶剂包括丙酮、乙酰丙酮、丁酮、环己酮；醚类溶剂包括乙醚、石油醚、乙二醇一甲醚。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011254045.3A CN112515070A (zh) | 2020-11-11 | 2020-11-11 | 一种含虾青素、牛磺酸、烟酰胺单核苷酸及电解质的运动饮料及制作方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011254045.3A CN112515070A (zh) | 2020-11-11 | 2020-11-11 | 一种含虾青素、牛磺酸、烟酰胺单核苷酸及电解质的运动饮料及制作方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112515070A true CN112515070A (zh) | 2021-03-19 |
Family
ID=74980758
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202011254045.3A Pending CN112515070A (zh) | 2020-11-11 | 2020-11-11 | 一种含虾青素、牛磺酸、烟酰胺单核苷酸及电解质的运动饮料及制作方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112515070A (zh) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113208117A (zh) * | 2021-06-03 | 2021-08-06 | 泰州职业技术学院 | 一种含有nmn和牛磺酸的组合物及其应用 |
| CN114246281A (zh) * | 2021-12-27 | 2022-03-29 | 山东佛坤投资有限公司 | 一种牡蛎肽海参肽运动型风味饮品及其制备方法 |
| CN114403443A (zh) * | 2022-02-14 | 2022-04-29 | 云南爱尔康生物技术有限公司 | 一种含虾青素的滴丸剂及其制备方法 |
| CN115316579A (zh) * | 2022-08-18 | 2022-11-11 | 上海玖咖科技有限公司 | 一种保健饮品及其制备方法 |
| WO2024154095A1 (en) * | 2023-01-20 | 2024-07-25 | Johnson & Johnson Consumer Inc. | Ready to drink electrolyte solution |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105831537A (zh) * | 2016-04-05 | 2016-08-10 | 杭州鑫伟低碳技术研发有限公司 | 一种抗疲劳虾青素的制备方法 |
| WO2016158212A1 (ja) * | 2015-03-31 | 2016-10-06 | 新興和製薬株式会社 | レスベラトロールとニコチンアミドモノヌクレオチドを含む食品組成物 |
| CN108308493A (zh) * | 2018-01-25 | 2018-07-24 | 江苏神华药业有限公司 | 一种含虾青素的抗疲劳固体饮料及制备方法 |
| CN109170907A (zh) * | 2018-08-30 | 2019-01-11 | 泓博元生命科技（深圳）有限公司 | 一种含有nmn的组合物、应用及运动饮料的制备方法 |
| CN111466502A (zh) * | 2020-04-14 | 2020-07-31 | 攀枝花学院 | 虾青素抗疲劳运动饮料及其制备方法 |
-
2020
- 2020-11-11 CN CN202011254045.3A patent/CN112515070A/zh active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016158212A1 (ja) * | 2015-03-31 | 2016-10-06 | 新興和製薬株式会社 | レスベラトロールとニコチンアミドモノヌクレオチドを含む食品組成物 |
| CN105831537A (zh) * | 2016-04-05 | 2016-08-10 | 杭州鑫伟低碳技术研发有限公司 | 一种抗疲劳虾青素的制备方法 |
| CN108308493A (zh) * | 2018-01-25 | 2018-07-24 | 江苏神华药业有限公司 | 一种含虾青素的抗疲劳固体饮料及制备方法 |
| CN109170907A (zh) * | 2018-08-30 | 2019-01-11 | 泓博元生命科技（深圳）有限公司 | 一种含有nmn的组合物、应用及运动饮料的制备方法 |
| CN111466502A (zh) * | 2020-04-14 | 2020-07-31 | 攀枝花学院 | 虾青素抗疲劳运动饮料及其制备方法 |
Non-Patent Citations (1)
| Title |
|---|
| 史海波等: "β-烟酰胺单核苷酸制备研究进展", 《精细化工中间体》 * |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113208117A (zh) * | 2021-06-03 | 2021-08-06 | 泰州职业技术学院 | 一种含有nmn和牛磺酸的组合物及其应用 |
| CN114246281A (zh) * | 2021-12-27 | 2022-03-29 | 山东佛坤投资有限公司 | 一种牡蛎肽海参肽运动型风味饮品及其制备方法 |
| CN114403443A (zh) * | 2022-02-14 | 2022-04-29 | 云南爱尔康生物技术有限公司 | 一种含虾青素的滴丸剂及其制备方法 |
| CN115316579A (zh) * | 2022-08-18 | 2022-11-11 | 上海玖咖科技有限公司 | 一种保健饮品及其制备方法 |
| WO2024154095A1 (en) * | 2023-01-20 | 2024-07-25 | Johnson & Johnson Consumer Inc. | Ready to drink electrolyte solution |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN112515070A (zh) | 一种含虾青素、牛磺酸、烟酰胺单核苷酸及电解质的运动饮料及制作方法 | |
| RU2156087C1 (ru) | Биологически активная добавка | |
| CN103750143B (zh) | 耐缺氧型抗疲劳能量组合物及其应用 | |
| CN103211147B (zh) | 一种提高皮肤活力美白肌肤的胶原蛋白营养粉 | |
| US6500451B2 (en) | Proenergetic food supplement based on NADH, octocosanol and vitamin E | |
| US20100124587A1 (en) | Creatine-containing vitamin and mineral composition | |
| CN103371317A (zh) | 一种核糖功能食品 | |
| CN101801219A (zh) | 恶病质预防补充剂 | |
| CN111466502A (zh) | 虾青素抗疲劳运动饮料及其制备方法 | |
| JP2023071851A (ja) | 組成物 | |
| Qiang | Effect of malate-oligosaccharide solution on antioxidant capacity of endurance athletes | |
| Zeviar et al. | The role of mitochondria in cancer and other chronic diseases | |
| CN111642668A (zh) | 一种含有β-烟酰胺单核苷酸的固体饮料及其制备方法 | |
| CN100386069C (zh) | 亮菌甲素脂质体制剂及其制备方法 | |
| Inagaki et al. | Rapid rehydration and moderate plasma glucose elevation by fluid containing enzymatically synthesized glycogen | |
| US20230091651A1 (en) | Dietary supplement and method for synthesis of same | |
| CN111297821A (zh) | 一种辅酶q10胶囊及其制备工艺 | |
| CN105724653A (zh) | 一种左旋肉碱绿茶减肥冲剂及其制备方法 | |
| CN111642741A (zh) | 一种肠道调节剂的生产工艺 | |
| RU2436415C2 (ru) | Композиция биологически активных веществ на основе бетулина с регулируемой скоростью высвобождения компонентов для снижения степени алкогольного опьянения, предупреждения и снятия алкогольной интоксикации и похмельного синдрома | |
| CN103798899A (zh) | 一种减肥饮料及其制备方法 | |
| CN1231213C (zh) | 一种解酒护肝的组合物及其制剂 | |
| CN117357469B (zh) | 一种盐酸肾上腺素注射液及其制备方法 | |
| US20230089537A1 (en) | Dietary supplement and method for synthesis of same | |
| CN101904535B (zh) | 多元强化益酒防醉苹果醋功能饮料口服液 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210319 |